• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Blood Use and Supply during the COVID-19 Pandemic: Early Lessons from Seattle

Physicians and colleagues from the Transfusion Medicine and Hematology Divisions at the University of Washington in Seattle and the local…

March 24, 2020

COVID-19 Pandemic Leading to Blood Supply Shortages

The worldwide pandemic of the novel coronavirus SARS-CoV-2, which causes COVID-19 disease (or coronavirus disease 2019), is disrupting every aspect…

March 17, 2020

National Survey Finds Stable Adverse Transfusion Reaction Rate in the U.S.

The 2017 National Blood Collection and Utilization Survey (NBCUS) used a web-based survey of approximately 3,000 U.S. community-based and hospital-based…

March 11, 2020

Risk of Transfusion Transmission of SARS-CoV-2 Is Only Theoretical

The novel coronavirus that was first reported in December 2019 from Wuhan, China has been renamed SARS-CoV-2, and causes the…

March 4, 2020

Minimal Residual Risk for HIV, Hepatitis B, and Hepatitis C from Blood Products

Based on screening results of over 58 million blood donations from the American Red Cross from more than 14.7 million…

February 28, 2020

Plasma Exchange Does Not Reduce Risk of Death for Patients with Severe ANCA-Associated Vasculitis

The underlying pathology behind antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is not clear; more effective and safer treatments are needed.  High-dose…

February 18, 2020

Final FDA Guidance to Reduce Transfusion-Transmitted Human T-Lymphotropic Virus Types I and II

Transmission of the retroviruses human T-lymphotropic virus types I and II (HTLV-I/II) require cell-to-cell contact—mother to child transmission, sexual transmission,…

February 12, 2020

New Draft Guidance Recommendations from the FDA to Reduce Risk of Transfusion-Transmitted Creutzfeldt-Jakob Diseases

Creutzfeldt-Jakob Disease (CJD) is a fatal, rare neurological disease caused by infectious prions, or abnormally folded proteins.  Sporadic CJD accounts…

February 5, 2020

World on Heightened Alert for Novel Coronavirus

Coronaviruses are a large family of enveloped RNA zoonotic viruses. The emerging novel coronavirus from Wuhan, China that was first…

January 28, 2020

Erythropoietin Does Not Provide Neuroprotection in Preterm Infants

In addition to stimulating red blood cell production, erythropoietin is a trophic factor in fetal brain development. Meta-analysis of four…

January 22, 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Interim pages omitted …
  • Page 63
  • Go to Next Page »

Primary Sidebar

Latest News

  • AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

  • Transfusion-related Alpha-Gal Syndrome

  • 2024 Serious Hazards of Transfusions (SHOT) Report in the U.K.

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley